ProMIS Neurosciences Correlations
| PMN Stock | USD 11.24 0.36 3.31% |
Low or negative correlation with other holdings can meaningfully reduce portfolio drawdowns during market stress. The current 90-days correlation between ProMIS Neurosciences and Edesa Biotech is 0.03 (i.e., Very good diversification).
Correlation With Market: ProMIS Neurosciences
Strong inverse diversification
ProMIS Neurosciences currently posts a -0.28 correlation with Dow Jones, indicating a Strong inverse diversification relationship for the active sample. This chart measures the degree of risk overlap between ProMIS Neurosciences and Dow Jones.
ProMIS |
Moving Against ProMIS Stock
| 0.5 | WINT | Windtree Therapeutics | PairCorr |
| 0.47 | DRMA | Dermata Therapeutics | PairCorr |
| 0.34 | VANI | Vivani Medical | PairCorr |
| 0.33 | EBS | Emergent Biosolutions | PairCorr |
| 0.62 | UPC | Universe Pharmaceuticals | PairCorr |
| 0.56 | EU6 | PDS Biotechnology Corp | PairCorr |
| 0.54 | XRTX | XORTX Therapeutics Trending | PairCorr |
| 0.54 | LIXT | Lixte Biotechnology | PairCorr |
| 0.48 | INSM | Insmed Inc Earnings Call This Week | PairCorr |
| 0.41 | X90 | PROBIOTIX HEALTH | PairCorr |
| 0.39 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.37 | GOSS | Gossamer Bio | PairCorr |
| 0.36 | ACW | Actinogen Medical | PairCorr |
Related Correlations Analysis
Please upgrade your account to get full access to Macroaxis premium features
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Return momentum in ProMIS Stock is more useful when tested against peer-relative fundamentals and risk. Without risk-adjusted context, short-term returns may appear stronger than the volatility required to achieve them would suggest. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MPLT | 3.67 | 0.93 | 0.24 | -3.06 | 3.13 | 8.66 | 30.44 | |||
| ERNA | 6.15 | -2.26 | 0.00 | 2.48 | 0.00 | 7.14 | 51.01 | |||
| OSRH | 4.99 | 0.17 | 0.03 | 0.21 | 5.42 | 13.21 | 22.07 | |||
| LPCN | 5.07 | -0.88 | 0.00 | -0.38 | 0.00 | 9.12 | 93.61 | |||
| ADAP | 12.64 | 0.58 | 0.04 | -0.10 | 15.04 | 22.82 | 168.52 | |||
| EDSA | 11.47 | 3.84 | 0.54 | -1.80 | 6.00 | 41.94 | 106.25 | |||
| ANL | 8.88 | 4.09 | 0.63 | 1.64 | 4.45 | 28.92 | 103.68 | |||
| GOVX | 4.18 | -1.34 | 0.00 | -1.67 | 0.00 | 7.26 | 36.65 | |||
| THAR | 4.96 | 0.36 | 0.06 | -0.69 | 5.86 | 10.70 | 29.73 | |||
| BRTX | 7.27 | -1.67 | 0.00 | -0.72 | 0.00 | 13.04 | 49.81 |
ProMIS Neurosciences Corporate Management
| Johanne Kaplan | Chief Development Officer | Profile | |
| David Wishart | Chief Physics Officer | Profile | |
| Larry MD | Chief Medical Officer | Profile | |
| Dennis Chen | Head of Manufacturing & Senior Consultant | Profile |